nVerses Capital’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-13,668
Closed -$56.4K – 190
2026
Q2
$56.4K Buy
+13,668
New +$59K 0.09% 271
2024
Q4
– Sell
-900
Closed -$9.6K – 688
2024
Q3
$9.6K Buy
+900
New +$8.45K ﹤0.01% 897

Other funds holding RCEL

nVerses Capital's RCEL Position: Q3 2026 in Review

nVerses Capital sold out of Avita Medical (RCEL) in Q3 2026, closing a stake of 13,668 shares — an estimated $56.4K sold.

nVerses Capital first reported a position in RCEL in Q3 2024 and held it in 2 quarters. The position peaked at $56.4K in Q2 2026. 89 funds tracked by Wall St. Rank hold RCEL as of Q3 2026.

  • nVerses Capital reported no remaining Avita Medical position as of Q3 2026 after selling out during the quarter.
  • nVerses Capital sold 13,668 Avita Medical shares in Q3 2026, an estimated $56.4K.
  • nVerses Capital first reported a position in Avita Medical in Q3 2024 and held it in 2 quarters.
  • nVerses Capital's Avita Medical position peaked at $56.4K in Q2 2026.
  • 89 funds tracked by Wall St. Rank held Avita Medical as of Q3 2026.

Based on nVerses Capital's 13F filing for Q3 2026.